Pfizer says Sutent fails in breast cancer studies phillyBurbs.com Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Pfizer ends study on potential lung cancer drug News 10NBC (AP) NEW YORK - Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, ...
Pfizer ends study on potential lung cancer drug San Luis Obispo Tribune By AP Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack ...
Pfizer says Sutent fails in breast cancer studies The Olympian Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Avastin Misses Prostrate-Cancer Goal Wall Street Journal Avastin, an antibody, is approved in the US and Europe for the treatment of advanced stages of colorectal cancer, breast cancer, non-small cell lung cancer ...
Pfizer says Sutent fails in breast cancer studies Las Vegas Sun Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Pfizer says Sutent fails in breast cancer studies Seattle Post Intelligencer Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
Roche's Avastin Fails to Meet Goal of Prostate Study Bloomberg The medicine is approved for several cancer types, including colorectal, lung and breast malignancies. Roche is seeking to expand use of the medicine, ...
Pfizer Ends Study on Potential Lung Cancer Drug New York Times ''This outcome is disappointing to us and to patients with non-small cell lung cancer,'' said Dr. Mace Rothenberg, senior vice president of clinical ...
Pfizer says Sutent breast cancer trials fail Times LIVE Pfizer said outside monitors concluded that the Phase 3 trial of figitumumab in patients with previously treated advanced non-small cell lung cancer was ...
Pfizer ends study on potential lung cancer drug BusinessWeek Pfizer Inc. said Thursday it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of ...
Pfizer says Sutent fails in breast cancer studies OneNewsNow Both breast cancer studies combined Sutent with chemotherapy and compared the effectiveness with patients only taking chemotherapy. ...
